Robert Weinstien Evidence and Decision Making in Apheresis Medicine

First Page		Document Content
Date: 2016-05-16 12:30:47 Transfusion medicine Autoimmune diseases RTT Hematology American Society for Apheresis Apheresis Plasmapheresis GuillainBarr syndrome Immunoglobulin therapy Myasthenia gravis Graft-versus-host disease Autoimmunity		Robert Weinstien Evidence and Decision Making in Apheresis Medicine Add to Reading List Source URL: www.hemapherese.fr Download Document from Source Website File Size: 945,83 KB Share Document on Facebook

	IPFA, bridging the interests of Donors – Collection Centers - Fractionation Centers - Patients IPFA is the international association for ‘not-for-profit’ organisations involved in the manufacture and/or supply of p DocID: 1qPH2 - View Document
	The emergence of HIV in the U.S. blood supply: Organizations, obligations, and the management of uncertainty KIERAN HEALY Princeton University DocID: 1qpOj - View Document
	Robert Weinstien Evidence and Decision Making in Apheresis Medicine DocID: 1pECv - View Document
	AABB, IHN & ISBT Working Group on Haemovigilance 2016 Donor Haemovigilance Case Validation Exercise Dear Colleague, Complications Related to Blood Donation Introduction and Instructions DocID: 1pwVs - View Document
	Journal of Clinical Apheresis 28:145–Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth DocID: 1pqG9 - View Document